Get started
Author

Dolores Hernández‐Maraver

Observed names: D Hernandez-Maraver, D Hernández, D Hernández Maraver, D Hernández-Maraver, D. Hernandez, D. Hernandez-Maraver, D. Hernndez Maraver, D. Hernández, D. Hernández-Maraver, Dolores Hernandez, Dolores Hernandez-Maraver, Dolores Hernandez‐Maraver, Dolores Hernández, Dolores Hernández-Maraver, Dolores Hernández, Dolores Hernández Maraver, Dolores Hernández-Maraver, Hernandez-Maraver D., Hernández-Maraver, Dolores
Observed institutions: Mayo Clinic, Centre Hospitalier Universitaire de Grenoble, Hospital Universitario La Paz, Organización Nacional de Trasplantes, Hospital La Paz Institute for Health Research, Centre Hospitalier Universitaire de Poitiers, Centre Hospitalier Universitaire d'Angers, Institut Bergonié, Hôpital Saint-Louis
ORCID: 0000-0001-5849-2069
Observed ORCID: 0000-0001-5849-2069
OpenAlex ID: A5021032009
Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study
2012 · Laura Rosiñol, Albert Oriol, et al. · Blood · 487
PDF
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
2012 · Robyn M. Emanuel, Amylou C. Dueck, et al. · Journal of Clinical Oncology · 458
PDF
PET/CT in lymphoma: prospective study of enhanced full-dose PET/CT versus unenhanced low-dose PET/CT.
2006 · Beatriz Rodríguez-Vigil, Nieves Gómez-León, et al. · PubMed · 136
Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients
2014 · Holly L. Geyer, Robyn M. Scherber, et al. · Blood · 91
Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group
2016 · Holly L. Geyer, Heidi Kosiorek, et al. · Haematologica · 77
PDF
Late reactivation of resolved hepatitis B virus infection: An increasing complication post rituximab‐based regimens treatment?
2008 · Maria J. Garcia‐Rodriguez, Miguel A. Canales, et al. · American Journal of Hematology · 66
PDF
Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease
2015 · Holly Geyer, Robyn Scherber, et al. · Journal of Clinical Oncology · 65
Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma
2006 · Dolores Hernandez‐Maraver, Fernando Hernandez‐Navarro, et al. · British Journal of Haematology · 64
PDF
Diagnostic value of CT, PET and combined PET/CT performed with low-dose unenhanced CT and full-dose enhanced CT in the initial staging of lymphoma.
2011 · I Pinilla, N Gómez-León, et al. · PubMed · 54
Thalidomide / Dexamethasone (TD) Vs. Bortezomib (Velcade)a/Thalidomide / Dexamethasone (VTD) Vs. VBMCP/VBAD/Velcadea as Induction Regimens Prior Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM): Results of a Phase III PETHEMA/GEM Trial.
2009 · Laura Rosiñol, Ma Teresa Cibeira, et al. · Blood · 45
Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation
2014 · C. Vallejo, M. Batlle, et al. · Haematologica · 33
PDF
A Phase III PETHEMA/GEM Study of Induction Therapy Prior Autologous Stem Cell Transplantation (ASCT) In Multiple Myeloma: Superiority of VTD (Bortezomib/Thalidomide/Dexamethasone) Over TD and VBMCP/VBAD Plus Bortezomib
2010 · Laura Rosiñol, María Teresa Cibeira, et al. · Blood · 33
Retrospective Multicenter Study of Extracorporeal Photopheresis in Steroid-Refractory Acute and Chronic Graft-versus-Host Disease
2020 · Gillen Oarbeascoa, Maria Luisa Lozano, et al. · Transplantation and Cellular Therapy · 31
Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs
2017 · Allison H. Scotch, Heidi Kosiorek, et al. · Leukemia Research · 28
Secondary acute myeloid leukemia and myelodysplasia after autologous peripheral blood progenitor cell transplantation
2001 · J. Sevilla, A. Rodríguez, et al. · Annals of Hematology · 28
Maintenance Therapy After Stem-Cell Transplantation for Multiple Myeloma with Bortezomib/Thalidomide Vs. Thalidomide Vs. alfa2b-Interferon: Final Results of a Phase III Pethema/GEM Randomized Trial
2012 · Laura Rosiñnol, Albert Oriol, et al. · Blood · 27
Autologous peripheral blood stem cell transplant in patients previously diagnosed with invasive aspergillosis
2001 · Sevilla J., Hernandez-Maraver D., et al. · Annals of Hematology · 20
Addressing Risks Derived From the Commodification of Substances of Human Origin: A European Proposal Applicable Worldwide
2023 · Natividad Cuende, Anna Vilarrodona, et al. · Transplantation · 19
Public Cord Blood Banks as a source of starting material for clinical grade HLA-homozygous induced pluripotent stem cells
2022 · Belén Álvarez-Palomo, Anna Veiga, et al. · Stem Cell Research & Therapy · 19
Immune Thrombocytopenic Purpura due to Disseminated Tuberculosis
2009 · D. Hernández-Maraver, J. Peláez, et al. · Acta Haematologica · 16
PDF
Recommendations for the treatment of invasive fungal infection caused by filamentous fungi in the hematological patient.
2011 · José Barberán, Josep Mensa, et al. · PubMed · 14
Promoting Equitable and Affordable Patient Access to Safe and Effective Innovations in Donation and Transplantation of Substances of Human Origin and Derived Therapies
2024 · Natividad Cuende, Stefan G. Tullius, et al. · Transplantation · 13
Myeloproliferative (MPN) Symptom Burden Response Thresholds: Assessment Of MPN-SAF TSS Quartiles As Potential Markers Of Symptom Response
2013 · Robyn M. Emanuel, Amylou Constance Dueck, et al. · Blood · 13
A 3-Case Series of Autoimmune Haemolytic Anaemia and COVID-19: Is Plasma Exchange an Alternative?
2021 · L. Ramos-Ruperto, Eduardo García-Pérez, et al. · SN Comprehensive Clinical Medicine · 11
PDF
Insomnia, Quality Of Life and MPN Symptom Burden: An Analysis By The MPN Quality Of Life International Study Group (MPN-QOL ISG)
2013 · Holly Lynn Geyer, Amylou Constance Dueck, et al. · Blood · 10
Works count: 91
Citation count: 1,990
H-index: 19
I10-index: 25
Year
Topic
Type